Journalclub

Datum Thema
ReferentIn
07.01.2020

Predictors and Moderators of Remission with Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression

Shriya H. Kaneriya, BA1,*, Gregg A. Robbins-Welty, BS1,*, Stephen F. Smagula, PhD2,*, Jordan F. Karp, MD2, Meryl A. Butters, PhD2, Eric J. Lenze, MD3, Benoit H. Mulsant, MD4, Daniel Blumberger, MD4, Stewart J Anderson, PhD5, Mary Amanda Dew, PhD2,6, Francis Lotrich, MD PHD2, Howard J. Aizenstein, MD PHD2, Breno S. Diniz, MD PHD7,8, and Charles F. Reynolds III, MD2,9

Jablan Ljudmila
14.01.2020 Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A Randomized Clinical Trial. Ibrahim Florence
21.01.2020 Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission The STOP-PD 11 Randomized Clinical Trial Alastair J. Flint, MB; Barnett S. Meyers. MD; Anthony J. Rothschild, MD: Ellen M. Whyte, MD: George S. Alexopoulos. MD: Matthew V. Rudorfer, MD;Patricia Marino. PhD; Samprit Banerjee, PhD; Cristina D. Pollari, MPH; Yiyuan Wu. MS; Aristotle N. Voineskos. MD, PhD; Benoit H. Mulsant, MD;for the STOP-PD li Study Group Gut Eva 
28.01.2020 Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrom

The Internation Tourette Sndrome Deep Brain Stimulation Public Database and Registry

Dahdal Philippe
04.02.2020 A prospective three-year follow-up study on the clinical significance of anti-neuronal antibodies in acute psychiatric disorders Alchihabi Roland 
11.02.2020 No substantial change in the balance between model-free and model-based control via training on the two-step task

Elmar D. Grosskurth1, Dominik R. Bach   2,3,4, Marcos Economides   3, Quentin J.M. Huys4, Lisa Holper  2* 

Grosskurth Elmar
18.02.2020 Communication of Emotion Via Drumming: Dual-brain Imaging With Functional Near-infrared Spectroscopy

Rahil Rojiani; Xian Zhang; Adam Noah; Joy Hirsch Soc Cogn Affect Neurosci. 2018;13(10):1047-1057.

Falk Dewa 
25.02.2020

A Randomized, Placebo-Controlled Study oft he Efficacy and Safty of Fixed-Dose Brexpiprazole  2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder“

2018, J Clin Psychiatry 2018;79(4):17m12058
Bouzas Gabrielle
03.03.2020  Can psychomotor disturbance predict ect outcome in depression?

Linda van Diermena,b,*, Simon Vanmarckea,b, Sebastian Waltherc, Herman Moensa, Eveline Veltmand, Erik Fransene, Bernard Sabbea,b, Roos van der Mastb,d, Tom Birkenhägerb,f, Didier Schrijversa,b

Weiss Florian 
10.03.2020

Anhedonia Reduction and the Association Between Left Ventral Striatal Reward Response and 6-Month Improvement in Life Satisfaction Among Young Adults 

Kristen L. Eckstrand, MD, PhD; Erika E. Forbes, PhD; Michele A. Bertocci, PhD; HenryW. Chase, PhD; Tsafrir Greenberg, PhD; Jeanette Lockovich, BSN; Ricki Stiffler, MSW; Haris A. Aslam, BS; Simona Graur, MSW; Genna Bebko, PhD; Mary L. Phillips, MD

Scotti Alessandra
17.03.2020

Am J Psychiatry. 2018 Mar 1;175(3):225-231. doi: 10.1176/appi.ajp.2017.17030325. Epub 2017 Dec 15. Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.

McGuire P1, Robson P1, Cubala WJ1, Vasile D1, Morrison PD1, Barron R1, Taylor A1, Wright S1. 

https://www.ncbi.nlm.nih.gov/pubmed/29241357

Baumann-Gama Daniel
24.03.2020 

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease 

Lawrence S. Honig, M.D., Ph.D., Bruno Vellas, M.D., Michael Woodward, M.D., Mercè Boada, M.D., Ph.D., Roger Bullock, M.D., Michael Borrie, M.B., Ch.B., Klaus Hager, M.D., Niels Andreasen, M.D., Ph.D., Elio Scarpini, M.D., Hong LiuSeifert, Ph.D., Michael Case, M.S., Robert A. Dean, M.D., Ph.D., Ann Hake, M.D., Karen Sundell, B.S., Vicki Poole Hoffmann, Pharm.D., Christopher Carlson, Ph.D., Rashna Khanna, M.D., Mark Mintun, M.D., Ronald DeMattos, Ph.D., Katherine J. Selzler, Ph.D., and Eric Siemers, M.D.

Abalasei Ioana
31.03.2020

“Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study”

JAMA Psychiatry Published online October 9, 2019 

Authors: Tiffany A. Greenwood, PhD; Laura C. Lazzeroni, PhD; Adam X. Maihofer, MS; Neal R. Swerdlow, MD, PhD; Monica E. Calkins, PhD; Robert Freedman, MD; Michael F. Green, PhD; Gregory A. Light, PhD; Caroline M. Nievergelt, PhD; Keith H. Nuechterlein, PhD; Allen D. Radant, MD; Larry J. Siever, MD; JeremyM. Silverman, PhD; William S. Stone, PhD; Catherine A. Sugar, PhD; DebbyW. Tsuang, MD; Ming T. Tsuang, MD, PhD, DSc; Bruce I. Turetsky, MD; Ruben C. Gur, PhD; Raquel E. Gur,MD, PhD; David L. Braff,MD

Maderthaner Lydia 
07.04.2020 Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia A Randomized Clinical Trial Leandro da Costa Lane Valiengo,MD, PhD; Stephan Goerigk, MSc; Pedro Caldana Gordon, MD, PhD; Frank Padberg, MD; Mauricio Henriques Serpa, MD; Stephanie Koebe, BSc; Leonardo Afonso dos Santos, MD; Roger Alberto Marcos Lovera, MD; Juliana Barbosa de Carvalho, BSc; Martinus van de Bilt,MD, PhD; Acioly L. T. Lacerda, MD, PhD; Helio Elkis, MD, PhD;Wagner Farid Gattaz, MD, PhD; Andre R. Brunoni, MD, PhD Affentranger Lucas
14.04.2020


AUSFALL - WIRD NACHGEHOLT!!!


Lead-Time Bias Confounds Association Between Duration of Untreated Psychosis and Illness Course in Schizophrenia

Katherine G. Jonas, Ph.D., Laura J. Fochtmann, M.D., Greg Perlman, Ph.D., Yuan Tian, M.Sc., John M. Kane, M.D.,

Evelyn J. Bromet, Ph.D., Roman Kotov, Ph.D.

 

Am J Psychiatry 177:4, April 2020

Forster Florian 
21.04.2020 Pregnancy outcomes in women with anorexia nervosa

Zharmaine Ante MScPH1,2 | Thuy Mai Luu MD MSc3 |Jessica Healy-Profitós MPH2,4 | Siyi He MScPH2,4 | Danielle Taddeo MD FRCPC5 | Ernest Lo PhD1,2 | Nathalie Auger MD MSc CPC1,2,4,6

Mani Glykeria 
28.04.2020 

Assessment of Pedophilia Using Hemodynamic Brain Response to Sexual Stimuli 

Jorge Ponseti, PhD; Oliver Granert, MSc; Olav Jansen, Prof MD; Stephan Wolff, MSc; Klaus Beier, Prof MD, PhD; Janina Neutre, MSc; Günther Deuschl, Prof MD; Hubertus Mehdorn, Prof MD;

Hartwig Siebner, Prof MD; Hartmut Bosinshi, Prof MD
Marini Lorenzo
05.05.2020 Quality of life and social functioning of former long-stay psychiatric patients transferred into the community: a 10 year follow up study.

Autoren: S.J. McInerney, S. Finnerty, E. Walsch, L. Spelman, N.E. Edgar, B. Hallahan, C. McDonald

Journal: Social psychiatry and psychiatric epidemiology (2018)

Drechsel Raida 
12.05.2020  Systolic Blood Pressure and Cognitive Decline in Older Adults With Hypertension  

Sven Streit, MD, MSc, PhD1, Rosalinde K.E. Poortvliet, MD, PhD2, Wendy P.J. den Elzen, PhD3, Jeanet W. Blom, MD, PhD2, Jacobijn Gussekloo, MD, PhD2,4

Fischer Samuel 
19.05.2020 A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia

Kenneth S. Koblan, Ph.D.,Justine Kent, M.O., Seth C. Hopkins, Ph.D.,John H. Krystal, M.O., Hailong Cheng, Ph.D., Robert Goldman, PhD, and Antony Loebel, M.O. 

Schulze Yves
26.05.2020

Incidence and Determinants of Mental Health Service Use After Bariatric Surgery 

David J. R. Morgan, MBBS; Kwok M. Ho, MBBS, PhD; Cameron Platell, MBBS, PhD

Secara Otilia
02.06.2020

A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder:

A Randomized Midazolam-Controlled Pilot Trial

Elias Dakwar, M.D., Frances Levin, M.D., Carl L. Hart, Ph.D., Cale Basaraba, M.P.H., Jean Choi, M.S., Martina Pavlicova, Ph.D.,Edward V. Nunes, M.D

Scotti Alessandra
09.06.2020 Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate
Kara Dempster1;  Peter Jeon2 ; Michael MacKinley3 ; Peter Williamson3,4,5 ; Jean Théberge 2,3,5,6 ;Lena Palaniyappan
Rüter Maximilian
16.06.2020  Regular Research Article Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant

in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

 

Maggie Fedgchin, Madhukar Trivedi, Ella J. Daly, Rama Melkote, Rosanne Lane, Pilar Lim, Dawn Vitagliano, Pierre Blier, Maurizio Fava,

Michael Liebowitz, Arun Ravindran, Raphael Gaillard, Hans van den Ameele, Sheldon Preskorn, Husseini Manji, David Hough, Wayne C. Drevets, Jaskaran B. Singh

Mansfield Franziska
23.06.2020 Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression A Randomized Clinical Trial

 

Roger S. McIntyre, MD; Mehala Subramaniapillai, MSc; Yena Lee, HBSc; Zihang Pan, HBSc; Nicole E. Carmona, HBSc; Margarita Shekotikhina, MD; Joshua D. Rosenblat, MD; Elisa Brietzke, MD, PhD; Joanna K. Soczynska, PhD; Victoria E. Cosgrove, PhD; Shefali Miller, MD; Eileen Grace Fischer, BSc;Nicole E. Kramer, MSc; Kiley Dunlap, MSc; Trisha Suppes, MD, PhD; Rodrigo B. Mansur,MD, PhD

Wetzel Dana
30.06.2020 Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone

 

Roberto Frau1,6, Vivien Miczán 2,3,6, Francesco Traccis1, Sonia Aroni1,4, Csaba I. Pongor5, Pierluigi Saba1, Valeria Serra1, Claudia Sagheddu1, Silvia Fanni1, Mauro Congiu1, Paola Devoto1, Joseph F. Cheer 4, István Katona 3,6 and Miriam Melis 1*

Kelava Benjamin
  Sommerpause bis 10.08.2020!  
11.08.2020 Nachtrag aus 04.2020 

Lead-Time Bias Confounds Association Between Duration of Untreated Psychosis and Illness Course in Schizophrenia

Katherine G. Jonas, Ph.D., Laura J. Fochtmann, M.D., Greg Perlman, Ph.D., Yuan Tian, M.Sc., John M. Kane, M.D.,

Evelyn J. Bromet, Ph.D., Roman Kotov, Ph.D.

 

Am J Psychiatry 177:4, April 2020

Forster Florian
18.08.2020 Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial

Pfister Tobias
25.08.2020 Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects

Anderson et al

JAMA Psychiatry, Publ. 08/2020

Wiedemann Andreas 
01.09.2020 Ausfall!! Kelava Benjamin 
08.09.2020 Predictors of suicide at time of diagnosis in schizophrenia spectrum disorder: A 20-year total population study in Ontario, Canada

Juveria Zaheer a,b,h,, Mark Olfson c,d, Emilie Mallia a,h,j, June S.H. Lamb,h, Claire de Oliveira a,e,f,k, David Rudoler e,f,g,h, Andre F. Carvalho h,b, Binu J. Jacob i, Ari Juda b, Paul Kurdyak a,b,f,j

Wagner En-Young 
15.09.2020 

Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms A Randomized Clinical Trial 

Zindel V. Segal, PhD; Sona Dimidjian, PhD; Arne Beck, PhD; Jennifer M. Boggs, PhD; Rachel Vanderkruik, MA; Christina A. Metcalf, MA; Robert Gallop, PhD; Jennifer N. Felder, PhD; Joseph Levy, BA

Aeschbacher Nadine
22.09.2020 In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine 

Jurjen J. Luykx, Noraly Stam, Antti Tanskanen, Jari Tiihonen and Heidi Taipale

Meyer Sarah
29.09.2020 Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia

Heidi Taipale*,1–3, Markku Lähteenvuo1, , Antti Tanskanen1,2, Ellenor Mittendorfer-Rutz2, and Jari Tiihonen1,2,4 1Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; 2 Department of Clinical

Neuroscience, Karolinska Institutet, Stockholm, Sweden; 3School of Pharmacy, University of Eastern Finland, Kuopio, Finland; 4Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden

Mäder Leonora
06.10.2020   Wirth Thomas 
13.10.2020   Wickenheisser Dennis 
20.10.2020   Gschwend Daniel 
27.10.2020    Auer Marlene 
03.11.2020   Neuhaus Gotlind 
10.11.2020   Iselin Barbara 
17.11.2020   Denier Niklaus 
24.11.2020   Chivu Camelia-Georgeta 
01.12.2020   Sociu Steluta 
08.12.2020    Blezinger Stephanie 
15.12.2020   Wissmann Thomas 
22.12.2020   Peyneshik Illiya 
  Feiertage bis 03.01.2021!